Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bogacka

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|December 14, 2004
Comparison of two design optimality criteria applied to a nonlinear modelBarbara Bogacka, Francis Wright
Statistical Methods in Medical Research|June 8, 2019
Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Computer Methods and Programs in Biomedicine|February 15, 2021
Model based dose personalization in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Journal of Biopharmaceutical Statistics|July 10, 2024
A constrained optimum adaptive design for dose finding in early phase clinical trialsM Iftakhar Alam, Barbara Bogacka, D Stephen Coad
Journal of Biopharmaceutical Statistics|May 27, 2015
Optimizing dose regimens and fixed dose combination ratios in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones, et al.
Statistics in Medicine|June 28, 2019
Combined criteria for dose optimisation in early phase clinical trialsM Iftakhar Alam, D Stephen Coad, Barbara Bogacka
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 27, 2016
[Pancreatic cancer microenvironment]Krzysztof Dąbkowski, Barbara Bogacka, Maciej Tarnowski, et al.
Journal of Biopharmaceutical Statistics|March 29, 2011
Optimum design of experiments for enzyme inhibition kinetic modelsBarbara Bogacka, Maciej Patan, Patrick J Johnson, et al.
Biometrics|January 29, 2017
Optimum designs for non-linear mixed effects models in the presence of covariatesBarbara Bogacka, Mahbub A H M Latif, Steven G Gilmour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2010
Potential application of D-optimal designs in the efficient investigation of cytochrome P450 inhibition kinetic modelsKuresh A Youdim, Anthony C Atkinson, Maciej Patan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|December 14, 2004
Comparison of two design optimality criteria applied to a nonlinear modelBarbara Bogacka, Francis Wright
Statistical Methods in Medical Research|June 8, 2019
Dose optimisation with simultaneous pharmacokinetic estimation in adaptive clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Computer Methods and Programs in Biomedicine|February 15, 2021
Model based dose personalization in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones
Journal of Biopharmaceutical Statistics|July 10, 2024
A constrained optimum adaptive design for dose finding in early phase clinical trialsM Iftakhar Alam, Barbara Bogacka, D Stephen Coad
Journal of Biopharmaceutical Statistics|May 27, 2015
Optimizing dose regimens and fixed dose combination ratios in clinical trialsKabir Soeny, Barbara Bogacka, Byron Jones, et al.
Statistics in Medicine|June 28, 2019
Combined criteria for dose optimisation in early phase clinical trialsM Iftakhar Alam, D Stephen Coad, Barbara Bogacka
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 27, 2016
[Pancreatic cancer microenvironment]Krzysztof Dąbkowski, Barbara Bogacka, Maciej Tarnowski, et al.
Journal of Biopharmaceutical Statistics|March 29, 2011
Optimum design of experiments for enzyme inhibition kinetic modelsBarbara Bogacka, Maciej Patan, Patrick J Johnson, et al.
Biometrics|January 29, 2017
Optimum designs for non-linear mixed effects models in the presence of covariatesBarbara Bogacka, Mahbub A H M Latif, Steven G Gilmour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 20, 2010
Potential application of D-optimal designs in the efficient investigation of cytochrome P450 inhibition kinetic modelsKuresh A Youdim, Anthony C Atkinson, Maciej Patan, et al.
Pageof 1